Raja Roti Cemerlang Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Raja Roti Cemerlang Tbk. trades at Rp65 (market cap 65.64B, 32.04M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 9.7× Raja Roti Cemerlang Tbk.'s market cap, and Raja Roti Cemerlang Tbk. is more actively traded (32.04M versus 843K). Which is the better fit depends on your goals.
| BRRC | LABS | |
|---|---|---|
Market Cap | 65.64B | 635.95B |
Volume | 32.04M | 843K |
Lot | 320.37K | 8.43K |
Turnover | 2.08B | 137.6M |
Average Price | 64.81 | 163.22 |
Value | 2.08B | 137.6M |
Indicative Equilibrium Price | 65 | 165 |
Indicative Equilibrium Volume | 18.28K | 246 |
Trailing returns across standard periods
Latest headlines on both assets
PT Raja Roti Cemerlang Tbk (the Company) was established based on Notarial Deed No. 5 dated September 21, 2015 of Dian Rohmah Yuniasari, S.H., M.Kn., notary in Bekasi. The Company begin its operation activities in 2015.
Read more on BRRC →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →